Serial cerebrospinal fluid neurofilament concentrations in bacterial meningitis

Journal of the Neurological Sciences

Volumn 280, Issue 1-2, 2009, Pages 59-61

  Matsushige, Takeshi ^a   Ichiyama, Takashi ^a   Kajimoto, Madoka ^a   Okuda, Masayuki ^b   Fukunaga, Shinnosuke ^a   Furukawa, Susumu ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Bacterial meningitis; Cerebrospinal fluid; Neurofilament

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; DEXAMETHASONE; NEUROFILAMENT PROTEIN;

ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; MALE; MENTAL DEFICIENCY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NERVE CELL LESION; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEWBORN; ONSET AGE; PARESIS; PERCEPTION DEAFNESS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; STREPTOCOCCUS PNEUMONIAE;

CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEARING LOSS, SENSORINEURAL; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, BACTERIAL; MENINGITIS, ESCHERICHIA COLI; MENINGITIS, HAEMOPHILUS; MENINGITIS, PNEUMOCOCCAL; MENTAL RETARDATION; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NEUROFILAMENT PROTEINS; PARESIS; TIME FACTORS;

EID: 63349098133     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.01.021     Document Type: Article

References (19)

1. Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 233 (2005) 183-198
2. Abdulle S., Mellgren A., Brew B.J., Cinque P., Hagberg L., Price R.W., et al. CSF neurofilament protein (NFL)-a marker of active HIV-related neurodegeneration. J Neurol 254 (2007) 1026-1032
3. Brettschneider J., Petzold A., Süßmuth S.D., Landwehrmeyer G.B., Ludolph A.C., Kassubek J., et al. Neurofilament heavy-chain NfH (SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes. Mov Disord 21 (2006) 2224-2227
4. Lewis S.B., Wolper R.A., Miralia L., Yang C., and Shaw G. Detection of phosphorylated NF-H in the cerebrospinal fluid and blood of aneurismal subarachnoid hemorrhage patients. J Cereb Blood Metab 28 (2008) 1261-1271
5. Mellgren A., Price R.W., Hagberg L., Rosengren L., Brew B.J., and Gisslén M. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection. Neurology 69 (2007) 1536-1541
6. Nylén K., Csajbok L.Z., Öst M., Rashid A., Karlsson J.E., Blennow K., et al. CSF-neurofilament correlates with outcome after aneurysmal subarachnoid hemorrhage. Neurosci Lett 404 (2006) 132-136
7. Petzold A., Eikelenboom M.J., Keir G., Grant D., Lazeron R.H., Polman C.H., et al. Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study. J Neurol Psychiatry 76 (2005) 206-211
8. Petzold A., Hinds N., Murray N.M., Hirsch N.P., Grant D., Keir G., et al. CSF neurofilament levels: a potential prognostic marker in Guillain-Barré syndrome. Neurology 67 (2006) 1071-1073
9. Rosén H., Karlsson J.E., and Rosengren L. CSF levels of neurofilament is a valuable predictor of long-term outcome after cardiac arrest. J Neurol Sci 221 (2004) 19-24
10. Tullberg M., Blennow K., Månsson J.E., Fredman P., Tisell M., and Wikkelsö C. Ventricular cerebrospinal fluid neurofilament protein levels decrease in parallel with white matter pathology after shunt surgery in normal pressure hydrocephalus. Eur J Neurol 14 (2007) 248-254
11. Zetterberg H., Jacobsson J., Rosengren L., Blennow K., and Andersen P.M. Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype. Eur J Neurol 14 (2007) 1329-1333
12. Lebel M.H., Freij B.J., Syrogiannopoulos G.A., Chrane D.F., Hoyt M.J., Stewart S.M., et al. Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med 319 (1988) 964-971
13. Shaw G., Yang C., Ellis R., Anderson K., Parker Mickle J., et al. Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury. Biochem Biophysiol Res Commun 336 (2005) 1268-1277
14. Petzold A., and Shaw G. Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain. J Immunol Methods 319 (2007) 34-40
15. Blennow M., Sävman K., Ilves P., Thoresen M., and Rosengren L. Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants. Acta Paediatr 90 (2001) 1171-1175
16. Kristjánsdóttir R., Uvebrant P., and Rosengren L. Glial fibrillary acidic protein and neurofilament in children with cerebral white matter abnormalities. Neuropediatrics 32 (2001) 307-312
17. Matsushige T., Ichiyama T., Anlar B., Tohyama J., Nomura K., Yamashita Y., et al. CSF neurofilament and soluble TNF receptor 1 levels in subacute sclerosing panencephalitis. J Neuroimmunol 205 (2008) 155-159
18. Petzold A., Keir G., Kay A., Kerr M., and Thompson E.J. Axonal damage and outcome in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 77 (2006) 753-759
19. Stevens J.P., Eames M., Kent A., Halket S., Holt D., and Harvey D. Long term outcome of neonatal meningitis. Arch Dis Child Fetal Neonatal Ed 88 (2003) F179-184